---
title: "Mr Stuart David Baker — Ownership Dossier"
canonical: https://whiteintel.dev/entity/494135ef-d065-4981-b32d-aee4e0a806cf
json: https://whiteintel.dev/api/public/dossier/494135ef-d065-4981-b32d-aee4e0a806cf
identifier: psc:NXd7lQo8f5zhfb-nopDsD5g_GCE
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Mr Stuart David Baker

**Type:** Person  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `psc:NXd7lQo8f5zhfb-nopDsD5g_GCE`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/494135ef-d065-4981-b32d-aee4e0a806cf  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/494135ef-d065-4981-b32d-aee4e0a806cf  

## Ownership & control

### Holdings / subsidiaries

- **NAPP PHARMACEUTICAL HOLDINGS LIMITED** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/658de06a-9248-5a00-8c1b-ba23cd78b41f

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Mr Stuart David Baker**. Human view: https://whiteintel.dev/entity/494135ef-d065-4981-b32d-aee4e0a806cf · Structured JSON: https://whiteintel.dev/api/public/dossier/494135ef-d065-4981-b32d-aee4e0a806cf._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._